Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Search for a Naturally Occurring Amylase Inhibitor in Human Serum

Abstract

IT has been postulated that an amylase inhibitor exists in normal human serum, but not in the serum of patients with acute pancreatitis1. The principal evidence for the presence of this inhibitor was based on observations that the average amylase activity of a group of sera was nearly tripled after subjecting the specimens to filter paper electrophoresis. It was found that when eighteen normal sera having a mean amylase value of 106 Somogyi units were separated electrophoretically, the total amylase recovered by extracting the various protein fractions with saline averaged 311 Somogyi units1. However, a similar electrophoretically-induced enhancement in amylase activity could not be demonstrated in sera from patients with acute pancreatitis. Dreiling et al.2 substantiated these observations and suggested that although increased quantities of pancreatic amylase enter the blood in acute pancreatitis, the circulating level of the amylase inhibitor is decreased in this disorder. These workers further concluded that, in cases of pancreatic cancer, hyperamylasaemia was not accompanied by any diminution in the enzyme inhibitor.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. McGeachin, R. L., and Lewis, J. P., J. Biol. Chem., 234, 795 (1959).

    CAS  PubMed  Google Scholar 

  2. Dreiling, D. A., Janowitz, H. D., and Josephberg, L. J., Ann. Internal Med., 58, 235 (1963).

    Article  CAS  Google Scholar 

  3. Wilding, P., Clin. Chim. Acta, 8, 918 (1963).

    Article  CAS  Google Scholar 

  4. Reif, A. E., and Nabseth, D. C., Clin. Chem., 8, 113 (1962).

    CAS  PubMed  Google Scholar 

  5. Pimstone, N. R., Clin. Chem., 10, 891 (1964).

    CAS  PubMed  Google Scholar 

  6. Sumner, J. B., J. Biol. Chem., 47, 5 (1921).

    Google Scholar 

  7. Dahlqvist, A., Scand. J. Clin. and Lab. Invest., 14, 145 (1962).

    Article  CAS  Google Scholar 

  8. Ujihira, I., Searcy, R. L., Berk, J. E., and Hayashi, S., Clin. Chem., 11, 97 (1965).

    CAS  PubMed  Google Scholar 

  9. Kalckar, H. M., J. Biol. Chem., 167, 461 (1947).

    CAS  PubMed  Google Scholar 

  10. Berk, J. E., Kawaguchi, M., Zeinh, R., Ujihira, I., and Searcy, R., Nature, 200, 572 (1963).

    Article  ADS  CAS  Google Scholar 

  11. Ujihira, I., Searcy, R. L., and Berk, J. E., Proc. Soc. Exp. Biol. and Med., 115, 996 (1964).

    Article  CAS  Google Scholar 

  12. Berk, J. E., Searcy, R. L., Hayashi, S., and Ujihira, I., J. Amer. Med. Assoc. (in the press).

  13. Searcy, R. L., Ujihira, I., Hayashi, S., and Berk, J. E., Clin. Chim. Acta, 9, 505 (1964).

    Article  CAS  Google Scholar 

  14. Searcy, R. L., Hayashi, S., Ujihira, I., and Berk, J. E., 148th Meeting Amer. Chem. Soc. (Abstract), 43C (Chicago 1964).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

HAYASHI, S., SEARCY, R., BERK, J. et al. Search for a Naturally Occurring Amylase Inhibitor in Human Serum. Nature 210, 92–94 (1966). https://doi.org/10.1038/210092a0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/210092a0

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing